Tobacco giant Philip Morris International (PMI) has bought a 22.61 percent stake in British asthma inhaler maker Vectura. Following the deal, PMI announced that it plans to continue acquiring Vectura shares on the market at 165p (RUB167) per share. informs CNBC.
PMI is interested in Vectura, as it believes that in the future, the acquisition of the company will allow it to earn more. The cigarette maker is counting on the absorption of Vectura, intending increase their revenues from the sale of goods and services not related to nicotine, up to a billion dollars a year. It is assumed that PMI will gain access to inhaler technologies for the production of alternative smoking systems, however, the production of the asthma drugs Vectura will continue after the takeover.
Read Also
- Even with screwdrivers: 150 Deportivo Cali fans are arrested in Argentina before the game against Boca May 26, 2022
- The ability of ASUS TUF Dash F15 in the eyes of professional gamers Apr 20, 2021
- Carlos Bianco signed a live criminal complaint against a Buenos Aires native who did not comply with quarantine Jul 19, 2021
- DR electrical service has been stabilized since last Thursday May 23, 2022
- NATO carried out a cooperative military exercise with Sweden and Finland and advances its inclusion in the Atlantic alliance Jun 3, 2022
- PS5 appears in Australia with a new model Aug 23, 2021
- JPMorgan Chase warns customers of possible data exposure Aug 18, 2021